scholarly journals 1090TiP A phase II, open label, multicenter study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with treatment-naïve metastatic Merkel cell carcinoma: The MERKLIN 1 study

2021 ◽  
Vol 32 ◽  
pp. S901-S902
Author(s):  
P.A. Ascierto ◽  
A.C.J. van Akkooi ◽  
P. Nghiem ◽  
F. Hermann ◽  
J-P. Henneberg ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Phase Ii ◽  
Multicenter Study ◽  
Merkel Cell ◽  
Efficacy And Safety ◽  
Open Label ◽  
Treatment Naïve

A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS9086-TPS9086 ◽  
Author(s):  
Howard Kaufman ◽  
Omid Hamid ◽  
Sandra P. D'Angelo ◽  
Guojun Yuan ◽  
Kevin M. Chin ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Phase Ii ◽  
Multicenter Trial ◽  
Clinical Activity ◽  
Merkel Cell ◽  
Open Label

scholarly journals 1089P POD1UM-201: A phase II study of retifanlimab (INCMGA00012) in advanced or metastatic Merkel cell carcinoma (MCC)

2020 ◽  
Vol 31 ◽  
pp. S739
Author(s):  
G. Grignani ◽  
M. Burgess ◽  
R. Depenni ◽  
M. Guida ◽  
F. Spagnolo ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Merkel Cell

scholarly journals Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

JAMA Oncology ◽  
2018 ◽  
Vol 4 (9) ◽  
pp. e180077 ◽  
Author(s):  
Sandra P. D’Angelo ◽  
Jeffery Russell ◽  
Céleste Lebbé ◽  
Bartosz Chmielowski ◽  
Thilo Gambichler ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Stage Iv ◽  
Merkel Cell ◽  
Efficacy And Safety ◽  
First Line
Sign in / Sign up

Export Citation Format

Share Document